a public good project by the
Synthesis
Company
of California

© 2026

Colin R. Dunstan | doi.page

0 works0 citations0 h-index

Colin R. Dunstan

Cardiff and Vale University Health Board(GB)

Publications by Year

Research Areas

Bone health and treatments, Bone Metabolism and Diseases, Bone health and osteoporosis research, Orthopaedic implants and arthroplasty, Bone Tissue Engineering Materials

Most-Cited Works

→ Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation(1998)5,439 cited
→ Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density(1997)5,099 cited
→ OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis(1999)3,346 cited
→ osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification(1998)2,471 cited
→ Increased bone formation in osteocalcin-deficient mice(1996)1,717 cited
→ Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand(1999)1,635 cited

→ TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling(1999)

1,267 cited

→ The Roles of Osteoprotegerin and Osteoprotegerin Ligand in the Paracrine Regulation of Bone Resorption(2000)1,181 cited

→ RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism(2000)1,123 cited

→ Stimulation of Osteoprotegerin Ligand and Inhibition of Osteoprotegerin Production by Glucocorticoids in Human Osteoblastic Lineage Cells: Potential Paracrine Mechanisms of Glucocorticoid-Induced Osteoporosis1(1999)794 cited